TV-46000

Teva's Risperidone Injectable Wards Off Schizophrenia Relapse in Phase III
BioSpace
Tue, 11/2/21 - 10:55 am
Teva Pharmaceutical
schizophrenia
clinical trials
Risperidone
TV-46000
Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia
Pharmaceutical Business Review
Fri, 01/8/21 - 09:24 am
Teva Pharmaceutical
MedinCell
TV-46000
clinical trials
schizophrenia